Results 121 to 130 of about 79,482 (238)

Biomarkers in cardiogenic shock: old pals, new friends

Annals of Intensive Care
In cardiogenic shock, biomarkers should ideally help make the diagnosis, choose the right therapeutic options and monitor the patient in addition to clinical and echocardiographic indices.
Mathieu Jozwiak, Sung Yoon Lim, Xiang Si, Xavier Monnet   +3 more
doaj   +1 more source

Mitochondrial Transplantation as a New Therapeutic Approach Against Cardiac and Renal Consequences in Male Rats With Myocardial Infarction

Acta Physiologica, Volume 242, Issue 6, June 2026.
ABSTRACT Aim Myocardial infarction (MI) is one of the leading causes of death worldwide. MI is associated with cardiac structural and functional alterations. Among these, cardiac fibrosis may be significantly influenced by mitochondrial dysfunction. We sought to evaluate whether the injection of functional mitochondria from healthy muscle could improve
María Cuesta‐Corral, Alejandro Montoro‐Garrido, Ana Romero‐Miranda, Fabián Islas, Bunty Ramchandani, Ricardo Gredilla, Joaquín Fernández‐Irigoyen, Enrique Santamaría, Beatriz Delgado‐Valero, Sara Jiménez‐González, Raquel Rodrigues Díez, María Luisa Nieto, Victoria Cachofeiro, Ernesto Martínez‐Martínez   +13 more
wiley   +1 more source

Cardiovascular Health in Women—Across the Lifespan

Clinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee   +5 more
wiley   +1 more source

Emergency PCI and TAVR for Acute Myocardial Infarction in Severe Aortic Stenosis Patients

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Transcatheter aortic valve replacement (TAVR) is a viable alternative for patients with symptomatic severe aortic stenosis. Acute myocardial infarction is a contraindication to TAVR. The efficacy of emergency TAVR combined with percutaneous coronary intervention for patients presenting with acute myocardial infarction, severe aortic stenosis ...
Ruiyuan Lin, Zheng Li, Zhen‐wei Liang, Yuan‐ Yao, Xian‐zi Zeng, Xiao‐mei Gao, Heng‐ Zhang, Zhuo‐Ya Li, Kun Wang, Xiao‐fei Jiang   +9 more
wiley   +1 more source

Mixed Cardiogenic-Vasodilatory Shock

JACC: Advances
This state-of-the-art review describes the potential etiologies, pathophysiology, and management of mixed shock in the context of a proposed novel classification system.
Jacob C. Jentzer, MD, David D. Berg, MD, MPH, Meshe D. Chonde, MD, Garima Dahiya, MD, Andrea Elliott, MD, Penelope Rampersad, MD, Shashank S. Sinha, MD, MSc, Alexander G. Truesdell, MD, Seife Yohannes, MD, Saraschandra Vallabhajosyula, MD, MSc   +9 more
doaj   +1 more source

Flecainide‐Induced Interstitial Lung Disease: A Case Report and Review of the Literature

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT This case describes a rare adverse effect in which the subject developed interstitial lung disease after initiating a class IC antiarrhythmic, flecainide. There is no current treatment recommendation for flecainide‐induced interstitial lung disease.
Elizabeth Jenkins, John McGinty, Brian Skinner   +2 more
wiley   +1 more source

Circulating Level of Growth‐Differentiation Factor 15 and Mortality of Patients With Acute Heart Failure: A Meta‐Analysis

Clinical Cardiology, Volume 49, Issue 5, May 2026.
Elevated admission GDF‐15 levels are associated with increased mortality in acute heart failure. This meta‐analysis of 10 studies (N = 3724) found a pooled RR of 2.82 (95% CI: 2.39–3.32; p < 0.001; I² = 0%), supporting GDF‐15 as a promising biomarker for early risk stratification in AHF patients.
Pingkui Jin, Yanjie Geng, Erwei Huo, Yanhong Xue, Daofeng You, Qinghou Zheng   +5 more
wiley   +1 more source

Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry [PDF]

, 2017
Aims To determine clinical correlates and optimal treatment strategy in patients with cardiogenic shock (CS) on admission. Methods and results In SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?
Buller, Christopher E., Harkness, Shannon M., Hochman, Judith S., Jeger, Raban V., Pfisterer, Matthias E., Ramanathan, Krishnan, Sleeper, Lynn A.   +6 more
core  

RNA Modifications: Current Understandings and Future Perspectives

MedComm, Volume 7, Issue 5, May 2026.
Types of RNA modification. We have summarized the currently common types of RNA modifications, including ac4C, m6A, m1A, m5C, m3C, m7G, and ψ, and visually characterized their features through structural formulas. The characteristic structures are marked with a background color different from the background color.
Shiyu Xiao, Tingwen Xiang, Chuan Yang, Xiaohua Wang, Gang Huang, Fei Luo, Zhao Xie, Yueqi Chen   +7 more
wiley   +1 more source

Intra-aortic balloon pump in cardiogenic shock: state of the art

Revista do Colégio Brasileiro de Cirurgiões
The clinical definition of cardiogenic shock is that of a low cardiac output and evidence of tissue hypoxia in the presence of adequate blood volume.
PETRONIO GENEROSO THOMAZ, LEONEL ADELINO MOURA JÚNIOR, GIOVANA MURAMOTO, RENATO SAMY ASSAD   +3 more
doaj   +1 more source